Ionis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development, has experienced a recent insider sell according to a SEC Filing.

Related Keywords

, Ionis Pharmaceuticals Inc , Drug Discovery And Development , Nsider Transaction , Insider Activity , Nsider Transactions ,